Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
hVIVO plc
HVOCurrent price
27.35 GBX
-0.61 GBX (-2.18%)
Last closed
27.8 GBX
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
192 710 894 GBX
Yield for 12 month
+40.98 %
1Y
3Y
5Y
10Y
15Y
HVO
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom. The company is involved in testing of vaccines and antivirals using human challenge clinical trials; and offers laboratory services, including assay development, cell based assays, compound efficacy and VRM, field trial bio-logistics, molecular, and biomarker analysis services. It provides services to big pharma and biotech organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, the company provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom. Address: 21 Plumbers Row, London, United Kingdom, E1 1EQ
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 830.72 GBXP/E ratio
9.4333Dividend Yield
0.7 %Current Year
+56 091 181 GBX
Last Year
+48 518 700 GBX
Current Quarter
+18 612 515 GBX
Last Quarter
+18 612 515 GBX
Current Year
+7 704 591 GBX
Last Year
+4 007 429 GBX
Current Quarter
+4 370 771 GBX
Last Quarter
+4 370 771 GBX
Key Figures HVO
1 year
3 years
5 years
10 years
EBITDA
14 657 621 GBX
Operating Margin TTM
PE Ratio
9.4333
Return On Assets TTM
11.97 %
PEG Ratio
–
Return On Equity TTM
58.05 %
Wall Street Target Price
2 830.72 GBX
Revenue TTM
67 267 814 GBX
Book Value
0.057 GBX
Revenue Per Share TTM
Dividend Share
0.002 GBX
Quarterly Revenue Growth YOY
29.8 %
Dividend Yield
0.7 %
Gross Profit TTM
9 079 804 GBX
Earnings per share
0.03 GBX
Diluted Eps TTM
0.03 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
31.1 %
Profit Margin
25.96 %
Dividend Analytics HVO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
18.04.2024
Forward Annual Dividend Yield
0.71 %
Last Split Factor
1:30
Payout Ratio
7.91 %
Last Split Date
14.12.2012
Dividend Date
–
Stock Valuation HVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
9.4333
Forward PE
17.6991
Enterprise Value Revenue
2.6168
Price Sales TTM
2.8648
Enterprise Value EBITDA
9.6041
Price Book MRQ
5.0059
Financials HVO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HVO
For 52 weeks
16.65 GBX
31.8 GBX
50 Day MA
28.47 GBX
Shares Short Prior Month
–
200 Day MA
28.18 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart